Hybrid compounds generated by the introduction of a nogalamycin-producing plasmid into Streptomyces argillaceus

The combination of genetic material from different antibiotic-producing organisms is a versatile and ever-expanding approach for the production of novel, hybrid compounds possessing bioactivity. The introduction of a plasmid (pSY21b) derived from Streptomyces nogalater and encoding PKS for nogalamycin production into the host strain S. argillaceus A43 led to the production of three new compounds in addition to the normally produced mithramycin. The new compounds are hybrids in the sense that they share features associated with the genes of both the host and the introduced plasmid. The structural elucidation of the novel compounds relied primarily on NMR spectroscopy, which revealed the thre…